Enzyme linked immunosorbent spot (ELISPOT) assay for interferon-gamma independently predicts renal function in kidney transplant recipients

American Journal of Transplantation

Volumn 3, Issue 7, 2003, Pages 878-884

  Hricik, Donald E ^a   Rodriguez, Victoria ^a   Riley, Jocelyn ^b   Bryan, Katherine ^b   Tary Lehmann, Magdalena ^c   Greenspan, Neil S ^c   Dejelo, Cora ^c   Schulak, James A ^c   Heeger, Peter S ^b,c  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ELISPOT; Immune monitoring; Interferon gamma; Kidney transplant

Indexed keywords

CREATININE; GAMMA INTERFERON;

ADULT; AGED; ALLOIMMUNITY; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; CYTOKINE PRODUCTION; DISEASE MARKER; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GRAFT FAILURE; HUMAN; IMMUNOASSAY; KIDNEY ALLOGRAFT REJECTION; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; MULTIPLE REGRESSION; OUTCOMES RESEARCH; PERIPHERAL LYMPHOCYTE; PREDICTION; RECIPIENT;

ADULT; AGED; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT REJECTION; HUMANS; INTERFERON TYPE II; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 0038690218     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2003.00132.x     Document Type: Article

References (29)

1. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988-96. N Engl J Med 2000; 342 (9): 605-612.
2. Cosio FG, Pelletier RP, Falkenhain ME et al. Impact of acute rejection and early allograft function on renal allograft survival. Transplantation 1997; 63 (11): 1611-1615.
3. Meier-Kriesche HU, Ojo AO, Hanson JA et al. Increased impact of acute rejection on chronic allograft failure in recent era. Transplantation 2000; 70 (7): 1098-1100.
4. Matas AJ, Humar A, Gillingham KJ et al. Five preventable causes of kidney graft loss in the 1990s: a single-center analysis. Kidney Int 2002; 62 (2): 704-714.
5. Suthanthiran M, Strom TB. Renal transplantation. N Engl J Med 1994; 331 (6): 365-376.
6. Gebauer BS, Hricik DE, Atallah A et al. Evolution of the enzyme-linked immunosorbent spot assay for post- transplant alloreactivity as a potentially useful immune monitoring tool. Am J Transplant 2002; 2 (9): 857-866.
7. Heeger PS, Greenspan NS, Kuhlenschmidt S et al. Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J Immunol 1999; 163 (4): 2267-2275.
8. Tary-Lehmann M, Hricik DE, Justice AC, Potter NS, Heeger PS. Enzyme-linked immunosorbent assay spot detection of interferon-gamma and interleukin 5-producing cells as a predictive marker for renal allograft failure. Transplantation 1998; 66 (2): 219-224.
9. Heeger PS, Hricik D. Immune monitoring in kidney transplant recipients revisited. J Am Soc Nephrol 2002; 13 (1): 288-290.
10. Li B, Hartono C, Ding R et al. Noninvasive diagnosis of renalallograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med 2001; 344 (13): 947-954.
11. Rush D, Somorjai R, Deslauriers R, Shaw A, Jeffery J, Nickerson P. Subclinical rejection - a potential surrogate marker for chronic rejection - may be diagnosed by protocol biopsy or urine spectroscopy. Ann Transplant 2000; 5 (2): 44-49.
12. Nickerson P, Jeffery J, Gough J et al. Identification of clinical and histopathologic risk factors for diminished renal function 2 years posttransplant. J Am Soc Nephrol 1998; 9 (3): 482-487.
13. Kasiske BL. Clinical correlates to chronic renal allograft rejection. Kidney Int Suppl 1997; 63: S71-S74.
14. Cosio FG, Falkenhain ME, Pesavento TE et al. Relationships between arterial hypertension and renal allograft survival in African-American patients. Am J Kidney Dis 1997; 29 (3): 419-427.
15. Baker RJ, Hernandez-Fuentes MP, Brookes PA, Chaudhry AN, Cook HT, Lechler RI. Loss of direct and maintenance of indirect alloresponses in renal allograft recipients. Implications for the pathogenesis of chronic allograft nephropathy. J Immunol 2001; 167 (12): 7199-7206.
16. Vella JP, Spadafora-Ferreira M, Murphy B et al. Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction. Transplantation 1997; 64 (6): 795800.
17. Ciubotariu R, Liu Z, Colovai AI et al. Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts. J Clin Invest 1998; 101 (2): 398-405.
18. Ng WF, Hernandez-Fuentes M, Baker R, Chaudhry A, Lechler RI. Reversibility with interleukin-2 suggests that T cell anergy contributes to donor-specific hyporesponsiveness in renal transplant patients. J Am Soc Nephrol 2002; 13 (12): 2983-2989.
19. VanBuskirk AM, Ferguson RM, Orosz CG. Clinical significance of MHC-reactive alloantibodies that develop after kidney or kidney-pancreas transplantation. Am J Transplant 2002; 2 (2): 134-141.
20. Susal C, Opelz G. Kidney graft failure and presensitization against HLA class I and class II antigens. Transplantation 2002; 73 (8): 1269-1273.
21. Murphy B. Genetic polymorphisms and transplantation. Am J Kidney Dis 2001; 38 (5): 1115-1118.
22. Filler G, Hocher B. The emerging role of gene polymorphisms determining outcome after solid- organ transplantation. Pediatr Transplant 2002; 6 (1): 12-14.
23. Hricik DE, Heeger PS. Minimization of immunosuppression in kidney transplantation. The need for immune monitoring. Transplantation. 2001; 72 (8 Suppl.): S32-S35.
24. Mayer TG, Fuller AA, Fuller TC, Lazarovits AI, Boyle LA, Kurnick JT. Characterization of in vivo-activated allospecific T lymphocytes propagated from human renal allograft biopsies undergoing rejection. J Immunol 1985; 134 (1): 258-264.
25. Ashwell JD, Chen C, Schwartz RH. High frequency and nonrandom distribution of alloreactivity in T cell clones selected for recognition of foreign antigen in association with self class II molecules. J Immunol 1986; 136 (2): 389-395.
26. Kerman RH, Kahan BD. Immunological evaluation of transplant rejection: pre and postoperative indices detecting immune responsiveness. Ann Clin Res 1981; 13 (4-5): 244-263.
27. Kerman RH, Floyd M, Van Buren C, McConnell BJ, McConnell R, Kahan BD. Correlation of nonspecific immune monitoring with rejection or impaired function of renal allografts. Transplantation 1981; 32 (1): 16-23.
28. Hariharan S, McBride MA, Cherikh WS, Tolleris CB, Bresnahan BA, Johnson CP. Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int 2002; 62 (1): 311-318.
29. Fink JC, Salmanullah M, Blahut SA et al. The inevitability of renal function loss in patients with hypercreatinemia. Am J Nephrol 2001; 21 (5): 386-389.